Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this survey is designed to investigate the treatment status of hypertensive
patient with metabolic syndrome-related risk factors treated with candesartan cilexetil
tablets (Blopress Tablets), as well as to assess relationships between risk factors (example,
visceral fat accumulation) and the incidence of cerebrovascular/cardiovascular events in an
exploratory manner.